Immune Network, InNexus Corp. deal

IMM granted a sublicense option allowing InNexus to apply SuperAntibody technology to IMMKF’s hNM01 and 1F7 antibodies to treat HIV infection/AIDS. SuperAntibodies are designed to add binding strength...